Do you want to read an article? Please log in or register.
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson A, Filho LVRDS, Melo J, Zampoli M, Carr SB
doi: 10.1016/j.jcf.2020.10.003
RECOMMENDED
Pulmonary Fibrosis
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, Prados-Sanchez C, Alvarez-Fernandez A, Garcia-Marcos PW, Peñalver-Mellado C, Pastor-Vivero MD, Olveira C, Lopez-Neyra A, Castillo-Corullon S, Palma-Milla S, Perez-Ruiz E, Sole-Jover A, Barrio MI, Sanchez-Solis M, Asensio de la Cruz Ó, CF-COVID19-Spain Registry Group
doi: 10.1016/j.rmed.2020.106062.
RECOMMENDED
Pulmonary Fibrosis
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros
Bain R, Cosgriff R, Zampoli M, Elbert A, Burgel PR, Carr SB, Castaños C, Colombo C, Corvol H, Faro A, Goss CH, Gutierrez H, Jung A, Kashirskaya N, Marshall BC, Melo J, Mondejar-Lopez P, de Monestrol I, Naehrlich L, Pastor-Vivero MD, Rizvi S, Filho LVRFDS, Brownlee KG, Haq IJ, Brodlie M
doi: 10.1016/j.jcf.2020.11.021
RECOMMENDED
Respiratory Tract Infection
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Infect Dis.
Tabata S, Imai K, Kawano S, Ikeda M, Kodama T, Miyoshi K, Obinata H, Mimura S, Kodera T, Kitagaki M, Sato M, Suzuki S, Ito T, Uwabe Y, Tamura K
doi: 10.1016/S1473-3099(20)30482-5.
RECOMMENDED
Pulmonary Fibrosis
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Berardis S, Verroken A, Vetillart A, Struyf C, Gilbert M, Gruson D, Gohy S
doi: 10.1016/j.jcf.2020.08.005.
Pulmonary Fibrosis
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
J Cyst Fibros
Pearson K, Mayer-Hamblett N, Goss CH, Retsch-Bogart GZ, VanDalfsen JM, Burks P, Rosenbluth D, Clancy JP, Hoffman A, Nichols DP
doi: 10.1016/j.jcf.2020.12.007
RECOMMENDED
Pulmonary Fibrosis
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
McLeod C, Wood J, Schultz A, Norman R, Smith S, Blyth CC, Webb S, Smyth AR, Snelling TL
doi: 10.1016/j.jcf.2020.08.015
RECOMMENDED
Respiratory Tract Infection
COVID-19
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur J Cancer
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C
doi: 10.1016/j.ejca.2021.10.014
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.